Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Hoffmann-La Roche
EMD Serono
Eli Lilly and Company
Emory University
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc